期刊文献+

siRNA干扰ARK5蛋白表达对U251细胞侵袭潜能影响机制探讨 被引量:2

Influence of siRNA interference ARK5 on the invasion potentiality of U251 cell and its mechanism
原文传递
导出
摘要 目的:探讨siRNA干扰降低腺苷酸活化蛋白激酶5(AMPK-related protein kinase 5,ARK5)表达对U251细胞侵袭潜能的影响及其机制。方法:采用蛋白质印迹法检测U251细胞中ARK5表达。应用siRNA干扰技术转染U251细胞株,并采用蛋白质印迹法检测瞬时转染后ARK5蛋白表达情况。通过体外侵袭实验检测细胞转染后侵袭能力的变化。ARK5下降后,蛋白质印迹法检测间质细胞来源的YKL-40、N-cadherin、Vimentin蛋白和调节因子Snail、Slug、Twist1和Zeb1的表达。结果:转染ARK5质粒的U251细胞ARK5表达下降。ARK5表达降低的U251细胞侵袭并穿透Matrigel膜基质的细胞数量为22,U251对照组为41,SCR/U251对照组为42,两两比较,ARK5表达降低的实验组透膜数比两对照组少(P<0.001),同时蛋白质印迹法结果显示,YKL-40、N-cadherin和Vimentin蛋白表达量降低,与间质转化相关的转录因子仅Snail的表达降低,而转录因子Slug、Twist1和Zeb1表达无明显改变。结论:应用siRNA干扰技术降低ARK5蛋白的表达使U251细胞侵袭转移能力降低,同时YKL-40、N-cadherin和Vimentin蛋白和转录因子Snail的表达量降低,提示ARK5蛋白表达降低可通过调节间质转化影响U251细胞的侵袭。 OBJECTIVE: To investigate the influence of invasion potentiality and its mechanism for U251 cell by siR- NA interference reducing ARK5. METHODS: Western blot was used to detect the expression of ARK5 in U251 ceils. SiR- NA plasmid was used to transfect U251 cells, then Western blot was used to analyze protein expression of ARK5. In vitro matrigel invasion assay was used to detect the variation of invasiveness in the cells being transfected. Western blot was used to analyze protein expression of YKL-40, N-cadherin, Vimentin and expression of transcription factor Snail, Slug, Twistl ,Zebl respectively. RESULTS: The protein expression of ARK5 in U251 cells that had been transfected by ARK5 was decreased. After downregulation of ARKS,the quantity of U251 cells which invaded and penetrated matriget was 22. The blank control group was 41, the control group of SCR/U251 was 42, compared with the two control groups, the quan- tity of U251 cells and the downregulation of ARK5 were decreased (P^0. 001). The protein expression of YKL-40, N-cadherin,Vimentin and only expression of transcription factor Snail were decreased significantly. CONCLUSIONS: Silen- cing of ARK5 impairs glioma cell invasion and the expression of ARK5 in glioma was signifieantly related with the expres- sion of YKL-40, N-cadherin,:Vimentin and Snail, suggesting that ARK5 can play a key role in the invasiveness of U251 by adjusting MT.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2014年第3期161-164,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(81072068) 山东省中青年科学家科研奖励基金(2010BSB14050)
关键词 U251 SIRNA干扰 腺苷酸活化蛋白激酶5 间质转化 侵袭 U2 51 siRNA interference ARK5 mesenchymal transition invasion
  • 相关文献

参考文献14

  • 1Suzuki A,Ogura T,Esumi H. NDR2 acts as the upstream kinase of ARK5 during insulinqike growth factor-1 signaling[J]. J Biol Chem,2006,281(20) : 13915-13921.
  • 2Suzuki A, Lu J,Kusakai G, et al. ARK5 is a tumor invasion-asso- ciated factor downstream of Akt signaling[J]. Mol Cell Biol, 2004,24(8) ..3526-3535.
  • 3Lu S,Niu N,Guo H, et al. ARK5 promotes glioma cell invasion and its elevated expression is correlated with poor clinical out- come[J]. Eur J Cancer,2013,49(3) :752-763.
  • 4Shi L, Sun X, Zhang J, et al. Gab2 expression in glioma and its implications for tumor invasion [ J ]. Acta Oncol, 2013, 52 (8) : 1739-1750.
  • 5燕慧,王捷.上皮间质转化与肿瘤转移的研究进展[J].中华肿瘤防治杂志,2010,17(4):311-314. 被引量:16
  • 6Lu KV, Chang JP, Parachoniak CA, et al. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEG- FR2 complex[J]. Cancer Cell, 2012,22 (1) : 21-35.
  • 7Zhang B,Gu F,She C,et al. Reduction of Akt2 inhibits migration and invasion of glioma cells[J]. Int J Cancer, 2009,125 (3) .. 585- 955.
  • 8姜京超,吕玉玲,纪宇明,姜慧峰,彭龙锋,王树兴,李学芝.人脑胶质瘤PTEN和Survivin及HIF-1α蛋白表达临床意义的探讨[J].中华肿瘤防治杂志,2012,19(20):1532-1534. 被引量:4
  • 9Van Trappen PO, Ryan A, Carroll M, et al. A model for co-ex- pression pattern analysis of genes implicated in angiogenesis and tumor cell invasion in cervical eancer[J]. Br J Cancer, 2002,87 (5) :537-544.
  • 10Fan JT,Si XH,Liao Y,et al. The diagnostic and prognostic value of serum YKL-40 in endometrial cancer[J]. Arch Gynecol Ob- stet,2013,287(1) : 111-115.

二级参考文献48

  • 1张飞,史玉荣,张霖,张斌,魏熙胤,杨毅,席广民,牛瑞芳.乳腺癌多药耐药细胞MCF-7/ADR中Twist的表达与EMT现象的实验研究[J].中国肿瘤临床,2007,34(7):361-365. 被引量:15
  • 2Hay E D. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it[J]. Dev Dyn, 2005, 233(3) :706-720.
  • 3Boyer B, Valles A M, Edme N. Induction and regulation of epithelial mesenchyrnal transitions[J]. Biochem Pharmacol, 2000, 60(8) : 1091-1099.
  • 4Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology [J]. Pathology, 2007, 39(3) :305-318.
  • 5Tepass U, Truong K, Godt D, et al. Cadherins in embryonic and neuml morphogenesis[J]. Nature Rev Mol Cell Biol, 2000, 1(2) :91-100.
  • 6Thiery J P. Epithelial-mesenchymal transition in tumor progression[J]. Nature Rev Cancer, 2002, 2(6) :442 -454.
  • 7Wells A, Yates C, Shepard C R. E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas[J]. Clin Exp Metastasis, 2008, 25(6):621-628.
  • 8Nawshad A, LaGamha D, Polad A, et al. Transforming growth factor-beta signaling during eplthelial-mesenchymal transforma tion: implications for embryogenesis and tumor metastasis[J]. Cells Tissues Organs, 2005, 179(1-2): 11-23.
  • 9Valcourt U, Kowanetz M, Niimi H, et al. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition[J]. Mol Biol Cell, 2005, 16(4): 1987-2002.
  • 10Zavadil J, Cermak L, Soto-Nieves N, et al. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition[J]. Embo J, 2004, 23(5) : 1155-1165.

共引文献18

同被引文献35

  • 1Yoshizumi M,Kyotani Y,Zhao J, et al. Role of big mitogen-aeti- rated protein kinase 1 (BMK1)/extracellular signal-regulated ki- nase 5 (ERKS) in the pathogenesis and progression of atheroscle-rosis[J]. J Pharmacol Sci, 2012,120 (4) : 259-263.
  • 2Yang Q, Lee JD. Targeting the BMK1MAP kinase pathway in cancer therapy[J].Clin Cancer Res,2011,17(11) :3527-3532.
  • 3Yang Q, Liao L,Deng X,et al. BMK1 is involved in the regula- tion of p53 through disrupting the PML-MDM2 interaction[J]. Oncogene, 2013,32(26) :3156-3164.
  • 4Lu KV, Chang JP, Parachoniak CA, et al. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex[J]. Cancer Ce11,2012,22(1):21-35.
  • 5Chen R, Yang Q, Lee JD. BMK1 kinase suppresses epithelial- mesenchymal transition through the Akt/GSK3β signaling path- way[J]. Cancer Res,2012,72(6) :1579-1587.
  • 6Onishi M, Ichikawa T, Kurozumi K, et al. Angiogenesis and in- vasion in glioma[J]. Brain Tumor Pathol,2011,28(1) :13-24.
  • 7Rizvi I, Gurkan UA, Tasoglu S, et al. Flow induces epithelial- mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules[J]. Proc Natl Acad Sci U S A,2013,110(22) :1974-1983.
  • 8Camand E, Peglion F, Osmani N, et al. N-cadherin expression level modulates integrin-mediated polarity and strongly impacts on the speed and directionality of glial cell migration[J]. J Cell Sci, 2012,125 (4) : 844-857.
  • 9Bellail AC, Hunter SB, Brat DJ, et al. Microregional extracel- lular rmatrix heterogeneity in brain modulates glioma ceil inva- sion[J]. Int J Biochem Cell Biol, 2004,36 (6) : 1046-1069.
  • 10燕慧,王捷.上皮间质转化与肿瘤转移的研究进展[J].中华肿瘤防治杂志,2010,17(4):311-314. 被引量:16

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部